Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Coronary Artery Disease: later-stage trial registry
57 of 220 indexed Coronary Artery Disease trials are currently recruiting, with more weight in Phase 3-4.
Corpus placement: #42 of 28,707 conditions by registered trial count.
220 US clinical trials · 57 currently recruiting · #42 of 28,707 conditions by registered trial count
Coronary Artery Disease: 220 US clinical trials tracked, 57 recruiting.
Coronary Artery Disease is the subject of 220 registered US clinical trials on ClinicalTrials.gov, 57 of them currently open to new participants. 42 are in Phase 3-4 (later-stage) and 15 in Phase 1-2 (earlier-stage). The most active sponsor is University of Florida, running 17 of these trials.
Enrollment posture brief
Registry condition coronary-artery-disease
OPEN 57 | RECR 26% | LATE 42 | EARLY 15 | RANK #42 | SPON 17
Volume-matched condition peers
Nearest open-share peer: Adenocarcinoma (26% recruiting · 27 trials)
Coronary Artery Disease lists 57 open slots (26% of 220 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Coronary Artery Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Coronary Artery Disease is recruiting below its size-band peers.
57 of 220 indexed trials (25.9%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Coronary Artery Disease trials is spread across many organizations.
University of Florida accounts for 17 of 220 trials (7.7%). 134 distinct sponsors appear on at least one study for this condition label.
-
Typical Coronary Artery Disease enrolment sits around 266 participants.
Median target enrolment is 266 among the 220 trials that report a genuine target (sentinel values excluded). 70 of those (31.8%) plan for fewer than 100 participants.
-
Coronary Artery Disease splits between interventional and observational designs.
153 interventional and 67 observational studies make up this index (69.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
220 total, page 3 of 5
An Observational Study of Cholesterol in Coronary Arteries
Infraredx
NCT00831116
EVOLVE Short DAPT Study
Boston Scientific Corporation
NCT02605447
Genotype Information and Functional Testing Study
Scripps Health
NCT00992420
PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease
Sino Medical Sciences Technology
NCT03168776
The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions
Boston Scientific Corporation
NCT00823212
PLATINUM Diversity
Boston Scientific Corporation
NCT02240810
TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent
Boston Scientific Corporation
NCT00292474
TAXUS PERSEUS Workhorse
Boston Scientific Corporation
NCT00484315
Study of Sirolimus-Coated BX VELOCITY Balloon-Expandable Stent in Treatment of de Novo Native Coronary Artery Lesions (SIRIUS)
Cordis US
NCT00232765
Implementation of CYP2C19 Genotyping to Guide Antiplatelet Therapy
University of Florida
NCT02724319
Drug Eluting Stent Registry of Thrombosis
Medstar Health Research Institute
NCT00812552
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
Gilead Sciences
NCT01425359
Enhancing Recovery After Cardiac Surgery
University of California, Los Angeles
NCT00522717
ISCHEMIA-Chronic Kidney Disease Trial
NYU Langone Health
NCT01985360
Radial Artery Access With Ultrasound Trial
University of California, Irvine
NCT01605292
Vitamins in Nitrous Oxide Study
Washington University School of Medicine
NCT00655980
Safety and Efficacy Study Using ABT-335 (Investigational Drug) in Combination With Atorvastatin, to Study the Effects on Thickening of the Blood Vessel Wall in Patients With Abnormal Lipid (Fat) Levels in the Blood
AbbVie (prior sponsor, Abbott)
NCT00616772
Predictor of Advanced Subclinical Atherosclerosis
PreMD
NCT00245284
Retrospective Experience Of CIED Implantation
Elutia
NCT04351269
Coronary Obstruction Detection by Molecular Personalized Gene Expression (Corus CAD or ASGES)
CardioDx
NCT01117506
Role of Podocan and Wnt Pathway Regulatory Molecules in Coronary Artery Disease
Jennifer Victory, RN, CCRC
NCT02807714
Gadobutrol / Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Bayer
NCT01890434
Improving Adherence to Post PCI Antiplatelet Therapy in Minority Populations
University of Miami
NCT01651208
OPTIMIZE PCI: Multicenter Randomized Trial of OCT Compared to IVUS and Angiography to Guide Coronary Stent Implantation
Abbott Medical Devices
NCT02471586
Enhancing Cardiac Rehabilitation Through Behavioral Nudges
Denver Health and Hospital Authority
NCT03834155
Disrupt CAD III With the Shockwave Coronary IVL System
Shockwave Medical
NCT03595176
Gadobutrol/Gadavist-enhanced Cardiac Magnetic Resonance Imaging (CMRI) to Detect Coronary Artery Disease (CAD)
Bayer
NCT01890421
Observational Study of OCT in a Patients Undergoing FFR
Abbott Medical Devices
NCT01663896
Restore EF Observational Study
Abiomed
NCT04648306
Stress Echocardiography and Heart Computed Tomography (CT) Scan in Emergency Department Patients With Chest Pain
Montefiore Medical Center
NCT01384448
The Health Access and Recovery Peer Program
Emory University
NCT01725815
GUARD-AKI: Validation of AKI-Sapere in Cardiac Surgery Patients
Sapere Bio
NCT03635606
Hemostasis With QuikClot® Radial® Pad Versus TR Band® After Transradial Artery Access
Memorial Healthcare System
NCT03535597
Periprocedural Glycemic Control in Patients Undergoing Coronary Angiography
NYU Langone Health
NCT01419652
Fractional Flow Reserve and Intravascular Ultrasound RelationShip STudy
Volcano Corporation
NCT01153555
Targeting Inflammation Using Salsalate in CardioVascular Disease
Joslin Diabetes Center
NCT00624923
Frequency Analysis of Coronary Artery Disease
University of Minnesota
NCT01043237
The OMEGA Clinical Trial
Boston Scientific Corporation
NCT01419171
COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT
CeloNova BioSciences
NCT01925794
Evaluating a Low-Literacy Discharge Medication Education Tool
University of California, Los Angeles
NCT00408733
Anti-inflammatory Effects of Colchicine in PCI
NYU Langone Health
NCT01709981
MARS - Monitored Atherosclerosis Regression Study
Merck Sharp & Dohme
NCT00116870
Same Day Discharge (SDD) After Implantable Cardioverter Defibrillator (ICD) Implant
Abbott Medical Devices
NCT01993862
Clinical Investigation for Safety and Efficacy Study of CELT ACD (Arterial ClosureDevice)
Vasorum
NCT01600482
Exercise Cardiac Magnetic Resonance Imaging Accuracy for Cardiovascular Stress Testing
Ohio State University
NCT01592565
The Platelet Aggregation After tiCagrelor Inhibition and FentanYl Trial (PACIFY)
Johns Hopkins University
NCT02683707
Non-Invasive EndoPAT Increases Diagnostic Yield of CAD by Coronary Angiography
Mayo Clinic
NCT01581671
Analysis of Surface EKG Signals to Identify Myocardial Dysfunction in Patients at Risk for Coronary Artery Disease
Icahn School of Medicine at Mount Sinai
NCT02560168
Determinants of Cardiac Risk Factor Modification in Latinos With Coronary Artery Disease
Weill Medical College of Cornell University
NCT00248859
WARRIOR Ancillary Study for CCTA Analysis
Cedars-Sinai Medical Center
NCT05035056
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 9 |
| Phase 3 | 17 |
| Phase 4 | 25 |
Top Sponsors
Named interventions
Most-linked intervention names on Coronary Artery Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Coronary Artery Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Coronary Artery Disease page
220 registered trials, 57 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 57 Coronary Artery Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Florida sponsors the most Coronary Artery Disease trials on record, review their full trial history before evaluating a specific study. See University of Florida's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Coronary Artery Disease condition card totals 220 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.